FIELD: medicine, physiotherapy in particular.
SUBSTANCE: invention relates to medicine, namely to physiotherapy, otolaryngology and neurology, and can be used for the physiotherapy of anosmia after a coronavirus infection. The object is consistently affected by a complex of physiotherapy methods. First, intranasal electrophoresis is performed using a 1% aqueous solution of thiamine hydrochloride. The procedure is performed in a sitting position according to the intranasal technique using a bifurcated electrode with a gradual increase in the duration of the procedures, a course of 10 procedures daily or every other day. In this case, the first three procedures are carried out with a current of 0.3 mA for 10 minutes. Subsequent procedures are carried out with a current of 0.5 mA and duration of: the fourth procedure is12 minutes, the fifth procedure 12-15 minutes, the sixth procedure 15 minutes, the seventh procedure 15-20 minutes, the eighth procedure 20 minutes, the ninth and tenth procedures 25 minutes. After electrophoresis, an intranasal exposure to low-level infrared laser radiation (LLLR) is performed without a time interval, at a wavelength of 904 nm. A nozzle for nasal laser therapy is used, pulse mode, pulse power at the output of the light guide 5 W/imp, the duration of the procedure is 5 minutes, a course of 10 procedures, daily or every other day. In this case, the nasal emitters are placed alternately in one, and then in the second nasal passages to a depth of no more than 1 cm, for 2.5 minutes of exposure in each.
EFFECT: method provides correction of olfactory function, improvement of microcirculation in the nasal mucosa due to the complex effect of the claimed physiotherapy methods.
1 cl, 1 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
USING METHOD FOR PREPARING CONDITIONED MEDIUM HAVING REGENERATIVE POTENTIAL FOR INTRANASAL ADMINISTRATION IN TREATING CHRONIC POST-VIRAL OLFACTORY DISORDERS | 2023 |
|
RU2816357C1 |
METHOD FOR TREATING DYSOSMIA CAUSED BY CORONAVIRUS INFECTION | 2021 |
|
RU2791808C2 |
USE OF PEPTIDE OF FORMULA MET-GLU-HIS-PHE-PRO-GLY-PRO FOR TREATING ANOSMIA IN COVID-19 | 2023 |
|
RU2816583C1 |
METHOD FOR PREVENTIVE TREATMENT OF CORONAVIRUS INFECTION | 2020 |
|
RU2777462C2 |
METHOD FOR ASSESSING THE THRESHOLD OF OLFACTION IN CHILDREN | 2021 |
|
RU2770290C1 |
METHOD OF TREATMENT OF PATIENTS WHO HAVE HAD NEW CORONAVIRUS INFECTION WITH LUNG DAMAGE IN THE EARLY RECOVERY PERIOD | 2022 |
|
RU2801234C1 |
METHOD FOR TREATMENT OF PATIENTS WITH NEW CORONAVIRUS INFECTION (COVID-19) | 2020 |
|
RU2745774C1 |
METHOD FOR CORONAVIRUS INFECTION TREATMENT | 2021 |
|
RU2751488C1 |
METHOD FOR CORRECTING COGNITIVE IMPAIRMENT IN PATIENTS DURING THE PERIOD OF CONVALESCENCE OF CORONAVIRUS INFECTION CASED BY THE SARS-CoV-2 VIRUS | 2022 |
|
RU2801379C1 |
METHOD FOR PROTECTION AGAINST CORONAVIRUS INFECTION | 2020 |
|
RU2747467C1 |
Authors
Dates
2021-07-19—Published
2021-04-22—Filed